- 4G Clinical is a global leader in randomization and trial supply management (RTSM) for the life sciences industry, offering a fully cloud-based and configurable solution that accelerates clinical trials using natural language processing.
- In August 2024, 4G Clinical appointed Dr. Ronan Brown as Chief Operating Officer and has been recognized for its rapid growth, ranking No. 28 on Inc. Magazine’s list of the Northeast Region’s Fastest-Growing Private Companies in March 2022.
- The company serves a diverse range of clients in the life sciences sector, leveraging its Prancer RTSM® technology to help organizations achieve First Patient In (FPI) up to 50% faster than competitors.
- 4G Clinical's ideal buyers are clinical trial sponsors and pharmaceutical companies looking to optimize trial efficiency and reduce drug waste, making it a critical partner for organizations aiming to expedite the delivery of new medicines.
The company comprises 12 distinct departments, with Operations leading in headcount at 67 employees, followed by Information Technology with 35 and Engineering with 25. This distribution indicates a strong focus on operational efficiency and technological development, essential for software innovation. The presence of Community and Social Services, with 17 employees, reflects a commitment to social responsibility, while the smaller departments, such as Human Resources and Education, suggest a streamlined approach to support functions.
The workforce is distributed across 38 locations, with Wellesley Hills, MA, housing the largest contingent at 36 employees. Other significant locations include Portland, OR, with 11 employees, and San Francisco, CA, and Boston, MA, each with 4 employees. The 'Other' category, accounting for 119 employees, indicates a remote or distributed workforce strategy, enhancing flexibility and access to talent across various regions. This geographic distribution suggests a concentrated operational hub while leveraging broader locations for diverse workforce engagement.
